721 related articles for article (PubMed ID: 17143041)
21. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
Lombardi F
Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
Cantillon DJ; Stein KM; Markowitz SM; Mittal S; Shah BK; Morin DP; Zacks ES; Janik M; Ageno S; Mauer AC; Lerman BB; Iwai S
J Am Coll Cardiol; 2007 Jul; 50(2):166-73. PubMed ID: 17616302
[TBL] [Abstract][Full Text] [Related]
23. Utility of T-wave alternans in congestive heart failure.
Deutsch A; Görenek B
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():82-4. PubMed ID: 17584689
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
[TBL] [Abstract][Full Text] [Related]
25. Risk stratification of ventricular arrhythmias in patients with systolic heart failure.
Vest RN; Gold MR
Curr Opin Cardiol; 2010 May; 25(3):268-75. PubMed ID: 20224387
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
Chan PS; Kereiakes DJ; Bartone C; Chow T
Am J Cardiol; 2008 Aug; 102(3):280-4. PubMed ID: 18638586
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
[TBL] [Abstract][Full Text] [Related]
28. T-wave alternans, restitution of human action potential duration, and outcome.
Narayan SM; Franz MR; Lalani G; Kim J; Sastry A
J Am Coll Cardiol; 2007 Dec; 50(25):2385-92. PubMed ID: 18154963
[TBL] [Abstract][Full Text] [Related]
29. Microvolt T wave alternans (MTWA)--a new non-invasive predictor of sudden cardiac death.
Predescu D; Mitruţ P; Giucă A
Rom J Intern Med; 2004; 42(3):647-56. PubMed ID: 16366137
[TBL] [Abstract][Full Text] [Related]
30. Sudden cardiac death: the role of risk stratification.
Kusmirek SL; Gold MR
Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900
[TBL] [Abstract][Full Text] [Related]
31. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
[TBL] [Abstract][Full Text] [Related]
32. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
Rashba EJ; Osman AF; Macmurdy K; Kirk MM; Sarang SE; Peters RW; Shorofsky SR; Gold MR
J Cardiovasc Electrophysiol; 2004 Feb; 15(2):170-6. PubMed ID: 15028046
[TBL] [Abstract][Full Text] [Related]
33. Comparability of noninvasive microvolt T-wave alternans versus invasive ventricular programmed stimulation to guide implantable cardioverter-defibrillator implantation in patients at risk of sudden death.
Feld GK; Clopton P
J Am Coll Cardiol; 2009 Feb; 53(6):480-2. PubMed ID: 19195604
[No Abstract] [Full Text] [Related]
34. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
35. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
36. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
[TBL] [Abstract][Full Text] [Related]
37. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
38. Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans.
Selvaraj RJ; Picton P; Nanthakumar K; Mak S; Chauhan VS
J Am Coll Cardiol; 2007 Jan; 49(3):338-46. PubMed ID: 17239715
[TBL] [Abstract][Full Text] [Related]
39. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event.
Armoundas AA; Albert CM; Cohen RJ; Mela T;
J Cardiovasc Electrophysiol; 2004 May; 15(5):594-7. PubMed ID: 15149432
[TBL] [Abstract][Full Text] [Related]
40. Immediate ventricular tachycardia after abnormal microvolt T-wave alternans.
Sedkowska A; Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Kalarus Z
Cardiol J; 2009; 16(4):365-7. PubMed ID: 19653182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
